A Clinical Study for the Evaluation of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on the Pharmacokinetics and Treatment Effects of Irinotecan in Patients With Colorectal and Gastric Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Irinotecan (Primary)
- Indications Colorectal cancer; Gastric cancer
- Focus Pharmacogenomic; Pharmacokinetics; Therapeutic Use
Most Recent Events
- 20 Aug 2007 New trial record.
- 25 Jul 2007 Biomarkers information updated